Edgar Staren, MD, PhD, and Stacie J. Stephenson, DC, to Address the Personalized Lifestyle Medicine Institute's Second Annual Thought Leaders Consortium

News provided by

Oct 23, 2014, 05:30 ET

BOCA RATON, Fla., Oct. 23, 2014 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America^® (CTCA) Chairman of Functional Medicine, Stacie J. Stephenson, DC, CNS, and Edgar Staren, MD, PhD, President, The Centers for Advanced Individual Medicine, have been selected by the Personalized Lifestyle Medicine Institute to speak at the second annual Thought Leaders Consortium to be held in Seattle, Washington, October 23-25, 2014. Dr. Stephenson will discuss "The Institutional Application of Personalized Lifestyle Medicine," while Dr. Staren will give a presentation entitled "Personalized Medicine and Oncology."

Drs. Stephenson and Staren will review advancements in the "personalization" of cancer treatment and management, specifically involving the interface between genomic medicine and oncology, and the institutional application of functional medicine. Dr. Stephenson will outline the unique approach of CTCA in it's delivery of functional medicine from an epigenetic perspective to oncology care that fully empowers each and every patient. CTCA patients are thoroughly engaged about every facet of their disease and potential treatment options. CTCA is committed to being at the forefront of patient centered care for each patient's specific, integrative therapy.

"The Thought Leaders Consortium is an pivotal opportunity to ignite the functional medicine model on personalized lifestyle medicine in practice," said Dr. Stephenson. "We believe that, by sharing the knowledge and experiences that govern our approach to treatment at Cancer Treatment Centers of America, we will empower our fellow healthcare thought leaders and practitioners with visionary, innovative approaches to personalized treatment, recovery, and prevention of cancer."

"This conference also offers us an excellent opportunity to discuss the emerging impact of genomic medicine and its increasing importance in the field of oncology," added Dr. Staren.

The Personalized Lifestyle Medicine Institute's Thought Leaders Consortium is a three-day event that brings together international thought leaders in a small group setting that offers a forum for professional development, networking opportunities, learning initiatives, and collaboration, as well as access to the latest information and innovations on how to address 21^st century healthcare related issues.

About Cancer Treatment Centers of America^®

Cancer Treatment Centers of America, Inc. (CTCA) is a national network of five hospitals that specialize in the treatment of patients fighting complex or advanced-stage cancer. CTCA offers an integrative approach to cancer treatment that combines surgery, radiation, and chemotherapy with nutritional counseling, naturopathic medicine, mind-body therapy, and spiritual support to enhance quality of life and minimize side effects during treatment. The company serves patients from all 50 states at hospitals located in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Known for delivering the Mother Standard^® of care and Patient Empowerment Medicine^®, CTCA provides patients with comprehensive information about their treatment options so they can participate in their treatment decisions. For more information about CTCA, go to www.cancercenter.com.

Logo - http://photos.prnewswire.com/prnh/20090612/CTCALOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/edgar-staren-md-phd-and-stacie-j-stephenson-dc-to-address-the-personalized-lifestyle-medicine-institutes-second-annual-thought-leaders-consortium-306120525.html

SOURCE Cancer Treatment Centers of America